Additional Positive Electric Residues in the Crucial Spike Glycoprotein S Regions of the New SARS-CoV-2 Variants

Código QR

Additional Positive Electric Residues in the Crucial Spike Glycoprotein S Regions of the New SARS-CoV-2 Variants

Piotr H Paw&lstrok;owski Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Warszawa, PolandCorrespondence: Piotr H Paw&lstrok;owski Tel +48-22-659-70-72Email piotrp@ibb.waw.plAbstract: The change in the formal charge of 34 SARS-CoV-2 lineages from September 2020 to June 2...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autor principal:	Pawłowski PH
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	coronavirus covid-19 sars-cov-2 spike protein s amino acids charge potential energy electrostatic interactions Infectious and parasitic diseases RC109-216
Acceso en línea:	https://doaj.org/article/26407dbcf8cd4aec9f9c12c527348f7a
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Decline of Humoral Responses against SARS-CoV-2 Spike in Convalescent Individuals
por: Guillaume Beaudoin-Bussières, et al.
Publicado: (2020)

Dynamics of SARS-CoV-2 Spike Proteins in Cell Entry: Control Elements in the Amino-Terminal Domains
por: Enya Qing, et al.
Publicado: (2021)

SARS-CoV-2 spike protein: Site-specific breakpoints for the development of COVID-19 vaccines
por: Palaniyandi Velusamy, et al.
Publicado: (2021)

Conserved molecular signatures in the spike protein provide evidence indicating the origin of SARS-CoV-2 and a Pangolin-CoV (MP789) by recombination(s) between specific lineages of Sarbecoviruses
por: Bijendra Khadka, et al.
Publicado: (2021)

In silico Identification of Characteristics Spike Glycoprotein of SARS-CoV-2 in the Development Novel Candidates for COVID-19 Infectious Diseases
por: Taufik Muhammad Fakih, et al.
Publicado: (2020)

Mutational Hotspot in the SARS-CoV-2 Spike Protein N-Terminal Domain Conferring Immune Escape Potential
por: Slawomir Kubik, et al.
Publicado: (2021)

D614G Substitution of SARS-CoV-2 Spike Protein Increases Syncytium Formation and Virus Titer via Enhanced Furin-Mediated Spike Cleavage
por: Ya-Wen Cheng, et al.
Publicado: (2021)

Inhibition of Coronavirus Entry <italic toggle="yes">In Vitro</italic> and <italic toggle="yes">Ex Vivo</italic> by a Lipid-Conjugated Peptide Derived from the SARS-CoV-2 Spike Glycoprotein HRC Domain
por: Victor K. Outlaw, et al.
Publicado: (2020)

Can the SARS-CoV-2 Spike Protein Bind Integrins Independent of the RGD Sequence?
por: Christopher A. Beaudoin, et al.
Publicado: (2021)

Introduction of Two Prolines and Removal of the Polybasic Cleavage Site Lead to Higher Efficacy of a Recombinant Spike-Based SARS-CoV-2 Vaccine in the Mouse Model
por: Fatima Amanat, et al.
Publicado: (2021)

SARS‐CoV‐2 infection shortly after BNT162b2 vaccination results in high anti‐spike antibody levels in nursing home residents and staff
por: Doris Urlaub, et al.
Publicado: (2021)

SARS‐CoV‐2 spike glycoprotein‐reactive T cells can be readily expanded from COVID‐19 vaccinated donors
por: Pavla Taborska, et al.
Publicado: (2021)

T cell epitopes of SARS-CoV-2 spike protein and conserved surface protein of Plasmodium malariae share sequence homology
por: Hassan Md. Mehedi, et al.
Publicado: (2021)

A rigorous framework for detecting SARS-CoV-2 spike protein mutational ensemble from genomic and structural features
por: Saman Fatihi, et al.
Publicado: (2021)

In silico investigation of binding affinities between human leukocyte antigen class I molecules and SARS-CoV-2 virus spike and ORF1ab proteins
por: Spyros A. Charonis, et al.
Publicado: (2021)

Stabilized coronavirus spike stem elicits a broadly protective antibody
por: Ching-Lin Hsieh, et al.
Publicado: (2021)

La Saliva como Biomuestra para Diagnóstico de Infección por SARS-CoV-2: Una Revisión
por: Morales-Espinosa,Rolando
Publicado: (2020)

Emerging mutation in SARS-CoV-2 spike: Widening distribution over time in different geographic areas
por: Ysrafil Ysrafil, et al.
Publicado: (2021)

A Review of Human Coronaviruses’ Receptors: The Host-Cell Targets for the Crown Bearing Viruses
por: Aaya Nassar, et al.
Publicado: (2021)

Electrochemical Immunosensor Platform Using Low-Cost ENIG PCB Finish Electrodes: Application for SARS-CoV-2 Spike Protein Sensing
por: Ruchira Nandeshwar, et al.
Publicado: (2021)

Site-Specific Glycosylation Patterns of the SARS-CoV-2 Spike Protein Derived From Recombinant Protein and Viral WA1 and D614G Strains
por: Yuan Tian, et al.
Publicado: (2021)

POTENTIAL, ELECTRIC FIELD AND SURFACE CHARGES CLOSE TO THE BATTERY FOR A RESISTIVE CYLINDRICAL SHELL CARRYING A STEADY LONGITUDINAL CURRENT
por: Hernandes,J. A., et al.
Publicado: (2004)

Phylogenetic and full-length genome mutation analysis of SARS-CoV-2 in Indonesia prior to COVID-19 vaccination program in 2021
por: Reviany V. Nidom, et al.
Publicado: (2021)

Differential pre-pandemic breast milk IgA reactivity against SARS-CoV-2 and circulating human coronaviruses in Ugandan and American mothers
por: Thomas G. Egwang, et al.
Publicado: (2021)

Improved SARS-CoV-2 Spike Glycoproteins for Pseudotyping Lentiviral Vectors
por: Paul G. Ayoub, et al.
Publicado: (2021)

Binding of the SARS-CoV-2 Spike Protein to the Asialoglycoprotein Receptor on Human Primary Hepatocytes and Immortalized Hepatocyte-Like Cells by Confocal Analysis
por: Collins DP, et al.
Publicado: (2021)

MG1141A as a Highly Potent Monoclonal Neutralizing Antibody Against SARS-CoV-2 Variants
por: Sua Lee, et al.
Publicado: (2021)

Coronil, a Tri-Herbal Formulation, Attenuates Spike-Protein-Mediated SARS-CoV-2 Viral Entry into Human Alveolar Epithelial Cells and Pro-Inflammatory Cytokines Production by Inhibiting Spike Protein-ACE-2 Interaction
por: Balkrishna A, et al.
Publicado: (2021)

Robust SARS-CoV-2 Antibody Responses in Asian COVID-Naïve Subjects 180 Days after Two Doses of BNT162b2 mRNA COVID-19 Vaccine
por: Chin-Shern Lau, et al.
Publicado: (2021)

SARS-CoV-2 en atención odontológica: vías de transmisión y sus consideraciones en la práctica clínica
por: Cruzat Villalobos,Gilena, et al.
Publicado: (2020)

Ultrasensitive Detection of SARS-CoV-2 Spike Proteins Using the Thio-NAD Cycling Reaction: A Preliminary Study before Clinical Trials
por: Yuta Kyosei, et al.
Publicado: (2021)

Concept Design of a High-Voltage Electrostatic Sanitizer to Prevent Spread of COVID-19 Coronavirus
por: Vahid Behjat, et al.
Publicado: (2021)

Pancreatitis aguda asociada a infección por SARS-CoV-2 en un paciente pediátrico
por: De la Barra,Sofía, et al.
Publicado: (2021)

Rapid Assessment of Binding Affinity of SARS-COV-2 Spike Protein to the Human Angiotensin-Converting Enzyme 2 Receptor and to Neutralizing Biomolecules Based on Computer Simulations
por: Damiano Buratto, et al.
Publicado: (2021)

Coronavirus (SARS-CoV-2): Preventions, keys to diagnosis and treatment of SARS-CoV-2
por: Kuldeep Singh Patel, et al.
Publicado: (2020)

SARS-CoV-2 Bearing a Mutation at the S1/S2 Cleavage Site Exhibits Attenuated Virulence and Confers Protective Immunity
por: Michihito Sasaki, et al.
Publicado: (2021)

Relative Ratios of Human Seasonal Coronavirus Antibodies Predict the Efficiency of Cross-Neutralization of SARS-CoV-2 Spike Binding to ACE2
por: Yannick Galipeau, et al.
Publicado: (2021)

SARS-CoV-2 B.1.1.7 Variant Infection in Malayan Tigers, Virginia, USA
por: Patrick K. Mitchell, et al.
Publicado: (2021)

Evolutionary and Antigenic Profiling of the Tendentious D614G Mutation of SARS-CoV-2 in Gujarat, India
por: Jay Nimavat, et al.
Publicado: (2021)

N501Y mutation of spike protein in SARS-CoV-2 strengthens its binding to receptor ACE2
por: Fang Tian, et al.
Publicado: (2021)